NATCO Pharma balance sheet

As of Mar 2026

Total assets: ₹11,074cr+28.3% on Mar 2025
Shareholders' equity: ₹9,221cr+21.1% on Mar 2025
Total debt: ₹706cr+158.7% on Mar 2025
Cash and investments: ₹777cr+76.3% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	2,545	2,432	2,298	2,239
	294	225	137	64.3
	63.0	57.4	56.0	55.2
	194	209	137	133
	2,276	—	—	—
	273	153	95.9	87.3
	62.0	182	43.9	17.0
	335	335	140	104
	233	50.1	19.4	34.5
	81.5	52.2	95.5	27.1
	6,021	3,361	2,883	2,657
	909	766	701	743
	578	321	444	305
	881	1,247	1,189	856
	199	120	70.4	132
	1,352	2,056	883	414
	9.8	9.4	9.0	10.2
	742	421	453	311
	3,762	4,173	3,047	2,028
	382	331	276	229
	5,052	5,270	4,024	3,000
	11,074	8,631	6,906	5,657
Equity
	35.8	35.8	35.8	36.5
	9,185	7,571	5,817	4,837
	9,221	7,607	5,853	4,874
	0.0	5.3	—	—
	9,221	7,612	5,853	4,874
Liabilities
	100	0.0	0.0	0.0
	9.7	9.2	9.3	2.8
	110	9.2	9.3	2.8
	61.8	65.6	70.9	85.3
	0.2	0.2	0.2	12.4
	172	75.0	80.4	101
	606	273	363	165
	409	275	236	264
	141	116	105	86.5
	1,157	664	704	515
	350	77.9	103	16.9
	0.5	79.0	32.3	10.1
	173	122	134	141
	1,681	944	973	683
	1,853	1,019	1,053	784
	11,074	8,631	6,906	5,657
Trade payables — MSME split
	27.8	17.6	—	—
	382	257	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NATCOPHARM₹793.00

NATCO Pharma Ltd.

· Pharma & Health

₹ CrorePeersDRREDDY ZYDUSLIFE SUNPHARMA LALPATHLAB NEULANDLAB NH SAILIFE COHANCEMcap ₹14,195 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	2,239.1	2,297.7	2,431.9	2,545.4	2,545.4
+ Capital Work-in-Progress	64.3	137.3	225.4	293.7	293.7
+ Goodwill	55.2	56.0	57.4	63.0	63.0
+ Other Intangibles	132.6	137.1	208.7	194.3	194.3
+ Investments (Equity Method)	—	—	—	2,275.7	2,275.7
+ Non-current Investments	87.3	95.9	152.8	273.2	273.2
+ Other Non-current Financial Assets	17.0	43.9	182.3	62.0	62.0
Non-current Financial Assets	104.3	139.8	335.1	335.2	335.2
+ Deferred Tax Assets	34.5	19.4	50.1	232.6	232.6
+ Other Non-current Assets	27.1	95.5	52.2	81.5	81.5
Total Non-current Assets	2,657.1	2,882.8	3,360.8	6,021.4	6,021.4
Current Assets
+ Inventories	742.9	700.5	765.8	908.5	908.5
+ Current Investments	305.0	443.5	320.8	578.2	578.2
+ Trade Receivables	856.1	1,188.9	1,246.6	881.2	881.2
+ Cash & Cash Equivalents	131.9	70.4	120.0	198.9	198.9
+ Other Bank Balances	414.4	882.5	2,056.0	1,352.0	1,352.0
+ Short-term Loans	10.2	9.0	9.4	9.8	9.8
+ Other Current Financial Assets	310.8	452.8	420.5	741.8	741.8
Current Financial Assets	2,028.4	3,047.1	4,173.3	3,761.9	3,761.9
+ Other Current Assets	229.0	275.9	330.9	381.9	381.9
Total Current Assets	3,000.3	4,023.5	5,270.0	5,052.3	5,052.3
Total Assets	5,657.4	6,906.3	8,630.8	11,073.7	11,073.7
Equity
+ Equity Share Capital	36.5	35.8	35.8	35.8	35.8
+ Other Equity / Reserves	4,837.3	5,817.3	7,571.2	9,185.3	9,185.3
Equity — Owners of Parent	4,873.8	5,853.1	7,607.0	9,221.1	9,221.1
+ Minority Interest	—	—	5.3	0.0	0.0
Total Equity	4,873.8	5,853.1	7,612.3	9,221.1	9,221.1
Liabilities
+ Borrowings — Non-current	0.0	0.0	0.0	100.0	100.0
+ Other Non-current Financial Liab	2.8	9.3	9.2	9.7	9.7
Non-current Financial Liabilities	2.8	9.3	9.2	109.7	109.7
+ Provisions — Non-current	85.3	70.9	65.6	61.8	61.8
+ Deferred Tax Liabilities	12.4	0.2	0.2	0.2	0.2
Non-current Liabilities	100.5	80.4	75.0	171.7	171.7
+ Borrowings — Current	165.0	363.2	273.1	606.4	606.4
+ Trade Payables	263.8	235.5	274.9	409.3	409.3
+ Other Current Financial Liab	86.5	104.8	116.3	141.4	141.4
Current Financial Liabilities	515.3	703.5	664.3	1,157.1	1,157.1
+ Provisions — Current	16.9	102.9	77.9	350.2	350.2
+ Current Tax Liabilities	10.1	32.3	79.0	0.5	0.5
+ Other Current Liabilities	140.8	134.1	122.3	173.1	173.1
Current Liabilities	683.1	972.8	943.5	1,680.9	1,680.9
Total Liabilities	783.6	1,053.2	1,018.5	1,852.6	1,852.6
Total Equity & Liabilities	5,657.4	6,906.3	8,630.8	11,073.7	11,073.7
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	17.6	27.8	27.8
+ Dues to Other Creditors — Current	—	—	257.3	381.5	381.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.